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ABSTRACT 
 
Alzheimer’s disease is a specific form of dementia characterized by the 
aggregation of Amyloid-β plaques and tau tangles. New research has found that 
the formation of these aggregates occurs after dysregulation of respiratory 
activity and the production of radical oxygen species. Proteomic data shows that 
these changes are also related to unique gene expression patterns. We 
investigate the impact of these findings on new therapeutic options via metabolic 
flux analysis of sirtuin stress response pathways and respiratory supercomplex 
formation. Our results indicate CRISPR Cas-based gene therapy focused on 
upregulating stable CIII expression, and protective changes in SIRT1 and AMPK 
expression are potential avenues for therapeutics. This work also highlights the 
importance of metabolic enzyme activity in maintaining proper respiratory activity.  
  
 
 
i 
 
TABLE OF CONTENTS 
Ackowledgements ii 
Dedication iii  
Introduction 1 
Methods 13 
Results 18 
Discussion 28 
References 31  
Appendix 39 
  
 
 
ii 
 
ACKNOWLEDGEMENTS 
 
I want to thank Professor Coleman for his guidance, patience and criticism 
throughout the investigation as well as Dr. Castora for thoughtful insight and helping 
me understand the broader scope of this research. Finally I want to thank Jess 
Crowley, Sonali Shirali and Zhenyu Han for their invaluable assistance in designing 
and understanding these models. Without them, I could not have completed this 
project.   
  
 
 
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This MS is dedicated to my late grandmothers. 
  
Modeling the effects of SC formation and stress response on AD progression            1 
 
 
 
Introduction 
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by the 
aggregation of neurofibrillary tangles and amyloid plaques (Cadenas & Davies, 2000; 
Grimm, Friedland, & Eckert, 2016). It is unclear if these aggregates cause cognitive 
degeneration or if they are a byproduct of other degenerative stimuli (Herrup, 2015). 
However, it is becoming increasingly apparent that mitochondrial impairment plays a 
significant role in the onset and progression of AD (Cai, Yan, Li, Quazi, & Zhao, 2012). 
Current research suggests that the mitochondrial efficiency plays a significant role on 
when and if a person develops dementia (Grimm et al., 2016; Mancuso, Orsucci, Siciliano, 
& Murri, 2008). With these new findings, researchers are looking into new ways to 
understand AD by studying changes in mitochondrial activity. Synthesis of this new 
research and older findings have produced two new theories about AD onset. The two 
theories are the Inverse Warburg Hypothesis (IW) and the Mitochondrial Cascade 
Hypothesis (MC) which explain the relationship between mitochondrial impairment and 
characteristic plaque buildup.  
Both the IW and MC theories were created to explain late onset AD (LOAD; 
Campion et al., 1999). The IW postulates that, prior to degeneration, there is an 
unsustainable increase in metabolic demand by neurons to compensate for respiratory 
inefficiency. Because neurons do not process glucose directly, they rely on astrocytes to 
process glucose into lactate which is then transferred from the astrocytes to the nearby 
neurons (Demetrius & Simon, 2013). One dysfunctional neuron’s elevated metabolic 
demand consumes a high concentration of the astrocyte’s limited glucose pool. The high 
consumption leaves nearby, healthy neurons lacking essential metabolites. Eventually the 
entire neuronal system begins collapsing leading to apoptosis and memory loss (Grimm 
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et al., 2016). There is no recorded evidence of the initial increase in metabolic demand 
that the IW theory predicts making it difficult to prove. 
 The MC hypothesis claims that genetics determine an innate level of respiratory 
chain efficiency. As people age, respiratory activity slows producing less ATP and more 
H2O2. During this process, minor impairments in the respiratory chain become more 
apparent. The subsequently high levels of ROS leave the mitochondria more susceptible 
to oxidative damage (Mosconi, 2013; Swerdlow, Burns, & Khan, 2010). ROS accumulation 
leads to activation of transcription factors peroxisome proliferator-activates receptor 
gamma, coactivator 1 (PGC1α) and forkhead box O3 (FOXO3) to increase mitochondrial 
biogenesis or induce autophagic pathways (Brenmoehl & Hoeflich, 2013). Proteomic data 
showing differences in gene expression support this theory. Compared to control tissue, 
nuclear encoded mitochondrial subunit expression is suppressed, and cell death related 
pathways are upregulated.   
We have created two models to investigate how changes in respiratory activity 
explained by these hypotheses influence mitochondrial viability as well as changes in 
stress signaling. Based on proteomic data, we investigated the impact changes in nuclear 
encoded subunits play in respiratory efficiency as well as how the related ROS production 
can influence gene transcription. During this investigation, we hope to better understand 
how the mitochondria reduces and responds to long term increases in oxidative stress as 
well as how to leverage these pathways to treat a serious underlying problem in AD 
affected brain cells.  
Respiratory Modeling 
Respiration is the process of oxidizing NADH and FADH2 to release electrons 
which reduce Coenzyme Q (CoQ) before being transferred to cytochrome C (cyt C) and 
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eventually convert O2 gas into water. This process is carried out across multiple respiratory 
complexes (RC), which pump high concentration of protons from the matrix into the 
intermembrane space (Murphy, 2009). A few decades ago, this was believed to occur 
across individual complexes embedded in the inner membrane. Today, two different 
models, fluid and solid state, have been proposed to describe how this transfer takes 
place. The fluid model which describes the electron transport chain (ETC) as separate 
complexes within the membrane. Once loaded or unloaded, CoQ and Cyt c diffuse until 
they reach the next complex in the RC (Letts, Fiedorczuk, & Sazanov, 2016). The solid 
state model proposes that individual complexes assemble to form a large multimeric 
complex known as the respirasome to be functional (Lapuente-Brun et al., 2013). In reality, 
the mitochondria functions with a spectrum of individual complexes, supercomplexes 
(SCs; functional intermediaries composed of a fraction of the complexes within the 
respirasome) and the respirasome. The purpose of these structures is unclear. SCs may 
reduce the diffusion distance of Cyt c and CoQ which may increase RC efficiency 
(Milenkovic, Blaza, Larsson, & Hirst, 2017).  Researchers have found that formation of the 
respirasome limits ROS production by stabilizing NADH dehydrogenase (CI) structure and 
covering one oxygen binding site on CI which plays a role in mitochondrial stress signaling 
(Stroud et al., 2016). SC assembly varies with cell state and type, which indicates SC 
formation could be physiologically significant and needs further exploration (Lopez-Fabuel 
et al., 2016).  
CI is the largest of the respiratory chain complexes, it oxidizes NADH and transfers 
the electrons to CoQ. This predominant producer of signaling-linked ROS contains two 
oxygen binding sites, one of which is protected when CI assembles to form the 
respirasome and other SCs. The two O2 binding sites are Flavin mononucleotide (FMN) 
and  N2 (an iron-sulfur cluster); oxygen binding at either location results in ROS production 
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(Acín-Pérez, Fernández-Silva, Peleato, Pérez-Martos, & Enriquez, 2008). Reverse 
electron transport (RET), which inefficiently reduces NAD when the Q pool is highly 
reduced and results in heightened levels of mitochondrial ROS (Lambert & Brand, 2004). 
RET occurs when CI, CoQ and later complexes become saturated with electrons. This 
ROS production seems to be linked to CI in its monomeric form, not as part of a complex 
with CIII or within the respirasome (Lenaz et al., 2010). Arthur, Morton, Dunham, Keeney, 
and Bennett (2009) found that the connection may in part be due to a slowed electron flow 
though CI and higher stability when part of an SC.  
If CI is not properly stabilized, increasing concentrations of ROS are produced 
causing mitochondrial oxidative stress (Cadenas & Davies, 2000; Liu et al., 2010; Ray, 
Huang, & Tsuji, 2012). This oxidative stress can activate signaling cascades which change 
gene transcription (Bechtel & Bauer, 2009). Changes in gene transcription can be seen 
by analyzing the changes in an organism’s proteome.  Our collaborators with Dr. Castora 
at Eastern Virginia Medical School have done analyses that show changes in 
mitochondrial biogenesis with AD.  Their analysis of tissues affected by AD indicate that 
the pathways related to the changes in ROS proliferation, defense, and energy production 
are altered. Our proposed mitochondrial models (SC assembly and oxidative stress) focus 
on the effects of oxidative stress on the antioxidant defense system and the induction of 
stress response signaling cascades. Through careful analysis we propose for effective 
therapy routes, SIRT1, AMPK and ETC subunit UQCRC1, for in vitro AD treatment testing.  
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Supercomplex assembly model 
After individual complexes have formed, complexes CI, Ubiquinone-Cytochrome 
C Reductase (CIII), and Cytochrome C Oxidase (CIV) begin to associate and form SCs. 
SCs are stable intermediates between respirasomes (solid state model) and individual 
complexes (fluid model). The two most prevalent SC compositions are CIVCIII2 and CICIII2 
(abbreviated CIVCIII and CICIII), the latter being more common (Ramírez-Camacho, 
Flores-Herrera, & Zazueta, 2019). The work by Maranzana et al. (2013), has implicated 
SCs in increasing respiratory efficiency and reducing ROS proliferation. SC and 
respirasome concentrations also vary between cell types. For example, astrocytes have 
been shown to have lower levels of SC formation, and this increases the basal level of 
ROS within the mitochondria (Lopez-Fabuel et al., 2016).  
Nuclear encoded ETC subunits are used to stabilize complexes as well as 
assemble SCs and respirasomes. The lesser found SC CIVCIII formation requires the 
COX7A2L isoform being present in CIV; it results in rapid assembly of the respirasome 
Figure 1A & B: 
The two pathways 
for respirasome 
formation involve 
two SC 
intermediates, 
CICIII and CIVCIII 
A: CICIII forms 
and assembles 
with CIV 
containing the 
COX7A2 subunit. 
B: CIVCIII forms 
using CIV with the 
COX7A2L subunit 
then with CI to 
form the final 
respirasome. 
B 
A 
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(Lobo-Jarne et al., 2018; Figure 1b).COX7A2, the shorter isoform,  within CIV leads to 
CICIII SC intermediate formation before final respirasome formation (Lapuente-Brun et 
al., 2013; Figure 1a). Within CIII, the expression of subunits, UQCRFS1, UQCRC1 and 
UQCRB ensure stable association with COX7A2L (Letts et al., 2016). CI association with 
the CIII dimer (usually forming CICIII2) reduces ROS formation in the mitochondria making 
the association highly favorable both in vivo and in vitro (Greggio et al., 2017). This 
association utilizes two bonding groups for stabilization including CI subunits NDUFB4 
and NDUFB9 which bind to CIII subunits UQCRFS1 and UQCRC1. CICIII also uses 
NDUFA11 and NDUFB4 to bond with UQCRQ (Letts et al., 2016; Stroud et al., 2016). 
Absence of one of these subunits does not prevent SC formation, but it does form a less 
stable association between individual complexes (Acin-Perez & Enriquez, 2014).  
An SC with a CICIII2CIV composition is known as a respirasome, but larger 
respirasome structures have been reported with up to four CIII and CIV present (Letts et 
al., 2016). Only 20% of mitochondrial CIV is incorporated into the respirasome compared 
to 55-65% of CIII and over 85% of CI (Greggio et al., 2017).This near complete 
Figure 2: Assembly of SC’s. is dependent on the expression of nuclear encoded 
subunits NDUFB9, NDUFA11, NDUFB4, NDUFS1 in CI and UQCRFS1, 
UQCRC1, and UQCRQ in CIII  
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incorporation of CI into SCs supports the hypothesis that all SC formation stabilizes CI 
and reduces ROS production (Maranzana et al., 2013). Lopez-Fabuel et al. (2016) report 
that CI subunit NDUFS1 deletion or downregulation has been shown to inhibit respirasome 
formation. This loss in vivo could significantly affect mitochondrial SC composition which 
in turn can change ROS production and mitochondrial signaling.   
Oxidative Stress Modeling 
Occasionally electrons escape ETC complexes during electron transport and 
create hydroxyl and superoxide radicals (Figure 3; Murphy, 2009; Sena & Chandel, 2012). 
Small amounts of ROS production is normal and easily regulated by constitutively 
expressed antioxidant proteins including superoxide dismutase (SOD2), Glutathione 
peroxidase (Gpx), Catalase (Cat) (Ighodaro & Akinloye, 2017). These proteins convert 
ROS into inert water or signaling molecules such as hydrogen peroxide. This is typical 
mitochondrial activity, but when more ROS is being produced than these antioxidant 
proteins can handle, oxidative stress signaling activates changes in gene expression to 
stop ROS accumulation or eliminate dysfunctional mitochondria (Ogura et al., 2018). 
PGC1α and FOXO3 are two important transcription factors that mitigate oxidative stress. 
They lead to the induction of antioxidant and autophagic proteins to include mitophagy 
Figure 3: The innate antioxidant system contains three enzymes SOD2, Cat 
and Gpx which process superoxide through a series of reaction to form inert 
water and oxygen gas. 
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which help eliminate terminally dysfunctional mitochondria and prevent cell apoptosis 
(Blacker & Duchen, 2016). Mitochondrial biogenesis is also altered by these changes in 
gene transcription which increase ETC subunit and antioxidant transcription. If these 
interventions fail, apoptosis is induced to prevent total cell dysfunction and cellular decay 
(Du & Yan, 2010).  
During the process of activating antioxidant systems, autophagy and apoptosis, 
pathological biomarkers of AD including amyloid aggregates and hyper phosphorylated 
tau are produced and accumulate, which amplifies these initial changes in gene 
transcription (Kim, Kim, Rhie, & Yoon, 2015). Based on the mitochondrial cascade 
hypothesis and the work done by Dr. Castora’s research group, we propose that gene 
therapies focused on reestablishing basal mitochondrial function, increasing ATP 
(adenosine triphosphate) and decreasing ROS production, we can successfully minimize 
or halt the accumulation of aggregates.  
Pathways 
Radical Quenching 
The ETC oxidizes NADH and FADH2 to create the membrane potential for 
oxidative phosphorylation. During this process, electrons can leak out of the ETC and 
create ROS (Starkov & Fiskum, 2003). To combat the production of excess ROS, the cell 
has evolved an antioxidant system involving two lines of defense; initial radical quenching 
and subsequent alterations in gene transcription (Ighodaro & Akinloye, 2017; Zhang et al., 
2018). Sirtuins (SIRTs) are a family of proteins predominately found within the cytosol, 
nucleus, and mitochondria. The two primary SIRTs found in the human brain are SIRT3 
and SIRT1 (Brenmoehl & Hoeflich, 2013). SIRT1 and SIRT3 use NAD to modulate the 
activation of local enzymes (Figure 4). When NADH levels are low and therefore NAD 
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levels are high, the cell can enter into an energy deprived or stressed state (Stein & Imai, 
2012). This causes an increase in NAD which increases SIRT activity making SIRTs 
valuable nutrient sensors. Their increased activity modulates enzyme activation via 
deacetylation to regulate enzyme activity in response to the cellular and mitochondrial 
NAD/NADH ratios (Brenmoehl & Hoeflich, 2013; Feldman, Dittenhafer-Reed, & Denu, 
2012). SIRT3 regulates the activity of antioxidant enzymes as well as the ETC and ATP 
synthase in the mitochondria (Kincaid & Bossy-Wetzel, 2013; Rangarajan, Karthikeyan, 
Lu, Ling, & Dheen, 2015). Metabolic activity in the nucleus and cytoplasm is modulated 
by SIRT1 (Cantó et al., 2009). When active, SIRT1 can activate multiple pathways related 
to antioxidant defense, cell metabolism, mitophagy and apoptosis (Feldman et al., 2012).  
The mitochondria keep an NAD/NADH ratio around 0-10 under normal conditions, 
allowing for low levels of SIRT3’s antioxidant activities and promoting cell longevity 
(Kincaid & Bossy-Wetzel, 2013). Deacetylation uses NAD which is converted into the 
sirtuin inhibiting molecule, NAM (nicotinamide; Guan, Lin, Knoll, & Chakrabarti, 2014). To 
permit continued SIRT activity, NAM must be converted back to NAD. This is done by two 
enzymes, NAMPT (nicotinamide phosphoribosyltransferase) and NMNPT (nicotinamide 
Figure 4: General SIRT1 and SIRT3 deacetylation mechanism. NAD is a cofactor and 
the enzymatic reaction produces inhibitor NAM which must then be converted back to 
NAD by NAMPT and NMNT. The rate limiting step in this regenerative cycle is the 
conversion of NMN to NAD (as shown by the thinner arrow).  
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mononucleotide adenylyltransferase; Figure 4). NAMPT is the rate limiting step in this 
reaction chain (Ling Liu et al., 2018). Slowing of NAMPT’s activity increases the NAM pool 
(Nikiforov, Dölle, Niere, & Ziegler, 2011).  
 Radical quenching is performed by the antioxidant enzyme system which includes 
SOD2, Cat, and Gpx (Ighodaro & Akinloye, 2017). Cat and SOD2 have low levels of 
activity under normal conditions, but SIRT3 increases their activity as ROS accumulates 
in the matrix (Chen et al., 2011; Rangarajan et al., 2015). This allows the mitochondria to 
conserve their energy and only induce energy demanding changes in gene expression 
under periods of stress. SOD2 converts radical oxygen into peroxide (Sun, Oberley, & Li, 
1988). Gpx uses two monomers of glutathione (GSH) to convert peroxide into water 
creating a glutathione dimer (GSSG) in the process. GSSG is then reduced to GSH by 
glutathione reductase (GR) so that Gpx can continue processing the peroxide being 
produced by SOD2 (Carlberg & Mannervik, 1975; Ighodaro & Akinloye, 2017). When there 
is a high concentration of glutathione dimers, common under oxidative stress conditions, 
SIRT3 deacetylates IDH2, catalyzing the reduction of glutathione dimers back to their 
monomeric state. (Yu, Dittenhafer-Reed, & Denu, 2012). If peroxide levels get too high, 
Cat will begin to convert the excess peroxide into water and oxygen (Bechtel & Bauer, 
2009). 
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Response Pathways 
Activation of AMP-activated protein kinase (AMPK) is the transition point from 
quick modifications of enzyme activity to changes in gene transcription to implement new 
stress response strategies (Figure 5) (Mihaylova & Shaw, 2011). AMPK activation is 
dependent on the AMP/ATP ratio, making it an energy sensor. The binding of AMP to 
AMPK results in increased activity of AMPK. Activation at high AMP/ATP ratios leads to 
the induction of PGC1α, FOXO3, and metabolic changes (Figure 6; Hart et al., 2015).  
Figure 5: Activation of 
AMPK requires both a 
phosphatase and AMP. 
Once activated, AMPK can 
phosphorylate many 
different proteins related to 
metabolism and oxidative 
stress regulation.   
Figure 6: Deacetylation of LKB1 results in AMPK activation under energy deficient 
conditions (high AMP). Activation of AMPK results in transcription factor activation 
and changes in metabolic activity increasing in NAD/NADH ratio and SIRT1 activity. 
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As ROS accumulate in the mitochondria, oxidative damage to the lipid bilayer, 
proteins and mtDNA will cause cellular stress and dysfunction. If there continues to be an 
increase in ROS production beyond the capacity of the antioxidant system, mitophagy will 
be activated and the mitochondria degraded (Mihaylova & Shaw, 2011). When the majority 
of mitochondria within a cell are dysfunctional, cell death can be initiated to prevent 
excessive consumption of valuable resources and deleterious signaling from hurting 
neighboring cells (Lukiw, 2004). This clearance requires changes in gene transcription. 
For this reason, one of the other targets of SIRT3 is the promoter FOXO3a. SIRT3 
deacetylates the protein allowing its export from the mitochondria to the cytosol and further 
posttranslational modifications which result in changes in mitochondrial gene transcription 
(Rangarajan et al., 2015).  
Before FOXO3a can be activated by AMPK, it must first be deacetylated by SIRT3 
in the mitochondria (permitting export to the cytosol), and SIRT1 in the cytosol. 
Phosphorylation allows for translocation to the nucleus and activation of different 
transcription factors. PGC1α is activated by initial deacetylation by SIRT1 in the nucleus 
Figure 7A & B: Transcription Factor Activation A. PGC1a activation increases 
antioxidant transcription and mitochondrial biogenesis. B. FOXO3a activation 
leads to mitochondrial degradation as well as increased antioxidant expression. 
 
A B 
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and subsequent phosphorylation by AMPK (Figure 7; Brenmoehl & Hoeflich, 2013; Zrelli, 
Matsuoka, Kitazaki, Zarrouk, & Miyazaki, 2011). In the nucleus, SIRT1 activates LKB1 via 
deacetylation. LKB1 can then activate AMPK (Zhang et al., 2018; Figure 6). These 
pathways are key to the initial response to changes in available glucose, energy and 
response to metabolic stress and ROS. In turn, these enzymes are regulated by ROS and 
cofactor levels within the brain. Once activated, FOXO3a will promote the transcription of 
SOD2, Cat, and different autophagic pathways (Cantó et al., 2009; Hart et al., 2015). 
Activation of the PGC1α promoter leads to increased antioxidant and biogenesis enzyme 
transcription (Figure 7; Sheng et al., 2012).  Its gene targets include: SIRT3, PGC1α, Nrf-
1 and nuclear respiratory factors (Nrf-1 and Nrf-2) that lead to changes in ETC and ATP 
synthase gene expression (Ruetenik & Barrientos, 2015).  
Methods 
These models were created in CellDesigner 4.2 and converted into a set of 
ordinary differential equations by SBMLsqueezer (Dräger, Hassis, Supper, Schröder, & 
Zell, 2008a; Xie, Allaire, & Grolemund, 2019). Model analysis was done in COPASI 
4.24.197 (Hoops et al., 2006). Every arrow within the model is represented by a “flux 
equation.” If the arrow represents formation of the specie, the flux value is positive (Figure 
8). If the reaction is using the specie, the reaction with have a negative value. These 
equations can describe catalyzed and uncatalyzed reactions. If the reaction is not enzyme 
catalyzed, the flux is described by a simple mass action equation (Equation 1). Like 
Michaelis-Menten (M-M), the mass action equation also has a rate constant (kcat) but 
unlike M-M, the overall rate is strictly dependent on the concentration of substrate present. 
If the reaction is enzyme catalyzed, then the equation takes the form of an M-M equation 
(2). M-M describes the rate of an enzymatic reaction using two constants. The first 
describes and enzyme’s binding affinity for its substrate(s), the M-M constant (Km). The 
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second describes the maximum rate of the reaction (kcat) (Equation 2).  For reactions with 
more than one substrate, the M-M equation is modified to accommodate a second 
substrate assuming a random order mechanism (Equation 3). This equation has an 
additional Km specific for the second substrate and an inhibition constant (Ki). Like M-M, 
bi-substrate random order mechanisms assume rapid equilibrium. Under these conditions, 
𝐾𝑖2𝐾𝑚1 =  𝐾𝑖1𝐾𝑚2  and the latter is simplified out of the final equation (Dräger, Hassis, 
Supper, Schröder, & Zell, 2008b). These equations are combined to form a series of Flux 
equations that describe the entire reaction (Figure 8).  
𝑘𝑐𝑎𝑡 ∗ [𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]       (1)  
𝑘𝑐𝑎𝑡∗[𝑒𝑛𝑧𝑦𝑚𝑒]∗[𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]
[𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]+𝐾𝑚
       (2) 
𝑘𝑐𝑎𝑡∗[𝑒𝑛𝑧𝑦𝑚𝑒]∗[𝑠1]∗[𝑠2]
𝐾𝑖2∗𝐾𝑚1+[𝑠1]∗[𝑠2]+𝐾𝑚1+𝐾𝑚2
      (3)  
Concentrations (uM) of proteins were calculated using brain tissue specific 
abundances from the Pax database and the molecular weights from the Uniprot database 
(The Uniprot Consortium, 2019; Wang, Herrmann, Simonovic, Szklarczyk, & von Mering, 
Figure 8: Flux equations describing the cleavage of APP protein to AB42. Each 
specie (APP, C99, and AB42) have a differential equation describing the change in 
concentration over time. Positive equations calculate the production of a specie, 
negative equations calculate the consumption of a protein. 
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2015). Metabolite concentrations were taken from the Human Metabolome Database 
(Wishart et al., 2018). Parameter values were assigned from the BRENDA database 
(Placzek et al., 2017).  
Model Assumptions 
SC Assembly 
SC assembly is a complex, reactive process of combining respiratory complexes 
into larger structures. As Late-Onset Alzheimer’s Disease is a slow degenerative disease, 
we followed the MC hypothesis that predicts small differences in RC subunit expression 
cause a change in respiratory efficiency which can leave neurons more susceptible to 
inflammation, oxidative damage, and cell death. The SC assembly model investigates how 
changes in gene expression, determined through proteomic analysis, influence SC 
assembly and sequestration of CI to reduce ROS formation. The initial model (Figure S1) 
considers the interactions between four CI subunits and five CIII nuclear encoded subunits 
not required for ETC function, but required to stabilize the complexes. The stability of the 
respirasome depends on the expression of associating subunits within each respiratory 
complex (Lenaz et al., 2010; Ramírez-Camacho et al., 2019). Figure S1 shows that the 
expression of different subunits, or the loss of subunits, produces respiratory complexes 
with differing levels of SC stability. Weaker connections cause an increase in ROS 
production as CI will not be fully stabilized by the SC formation (parameters and equations 
can be found in the supplement, S3 and S2). When the concentrations of subunits are 
considered (Table 1), and assuming preference for creating complexes with all of the 
subunits, S1 is reduced to the model shown in Figure 9. 
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The high concentration of NDUFS1 predicts that assembly favors respirasome 
formation. Missing one or two subunits results in a weaker association (s2CICIII). When 
the complexes contain all of the stabilizing subunits, the SC is less likely to disassemble 
and forms a complete respirasome at a faster rate. The availability of predominant CIV 
COX7 isoforms COX7A2 and COX7A2L determines whether SC CICIII or CIVCIII will form 
(Lobo-Jarne et al., 2018). 
Antioxidant Model 
In living cells, the NAD/NADH pools are linked through the reduction and oxidation 
of various metabolites to connect glycolysis in the cytosol to energy production in the 
mitochondria. These two separate pools have differing NAD/NADH ratios to facilitate 
normal compartment activity, energy production within the mitochondria, and cofactors in 
the cytosol. AMPK also regulates the NAD/NADH ratio in the cytosol, as it does in vivo 
Figure 9: Based on cellular subunit concentrations, the model was reduces to 
a combination of six complex types that could assemble to form one of three 
SCs and complete respirasome.  
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(Cantó et al., 2009).  In this model, we assumed that the two pools were separate and that 
the local changes in the NAD/NADH ratios are only changing in response to respiratory 
activity, ROS production and AMPK-mediated metabolic changes. ATP consumption was 
also generalized to hydrolysis of ATP to AMP rather than ADP. Though both do happen, 
the simplification to only show ATP and AMP levels was done to show ATP consumption 
as well as activation of AMPK through AMP binding The ETC concentration is also 
assumed due to stable complexes not missing subunits.   
Parameter Optimization 
The final parameter set for the oxidative stress models was found by providing an 
initial parameter set. This set was created based on rate constants found in the BRENDA 
database. Those that could not be found were given an initial value of 0.01 for Km and 1 
Figure 10: The mitochondria model being simulated to test analyze the activation of 
transcription factors and antioxidant system capacity.  
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for kcat. The initial and final parameter sets can be found in the supplement (S7 and S6). 
Parameter units for kcat, and Km are min-1 and uM respectively.  This set underwent an 
optimization using the Hooke and Jeeves solver in COPASI to produce the final parameter 
set. These adjusted values better illustrate true pathway activity.  
Sensitivity data 
A sensitivity analysis (SA) of the oxidative stress model was performed to quantify 
sensitive points within the model system. The task perturbs one specie concentration by 
1%, and COPASI records how this change effects the dependent variables of the system 
(reaction rates and transient concentrations). The results are presented as the average 
percent dependency of a dependent variable’s value on the initial concentration being 
varied. This analysis is only accurate for perturbations up to 5%, higher changes in 
concentration deviate from the predicted trend. 
Treatment Tests 
Treatment data was determined using COPASI’s time course analysis. Each 
treatment mimics the effects of CRISPR-Cas type gene therapy and was done by 
adjusting the protein concentration up or down 50%. Steps of 0.1 minutes were used to 
record transient concentration values over the course of a 100 minute simulations. Most 
data is presented as the percent difference between the control model and the treatment 
model. Calculations and graphing were done in RStudio (3.5.2) by finding the difference 
between treatment (up or down regulation) groups and the control then dividing by the 
control concentration and multiplying by 100.  
Results 
The two models produced data explaining different aspects of mitochondrial 
dysfunction and potential treatment directions. The SC assembly model demonstrates 
how differences in AD and healthy gene expression can change the concentration of SC‘s 
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and respirasomes in the cells which has wider impacts on mitochondrial efficiency. The 
oxidative stress model shows that an increase in ROS due to structural or other changes 
in SC content and formation observed in the SC assembly model can impact the activation 
of transcription factors. Together these therapeutic tests provide valuable information on 
how changes in subunit or enzyme expression can influence further changes in gene 
transcription in response to superoxide production.  
SC Assembly Results  
The formation of SC’s varies between cell types and is implicated in ROS 
production (Acin-Perez & Enriquez, 2014). The uniqueness of SC formation to cell types 
predicts that changes in assembly will have widespread effects on mitochondrial and 
subsequently cellular homeostasis. To understand how AD affects respirasome formation 
and to grow intuition about how increasing subunit expression can either alleviate or 
exacerbate these issues, we simulated SC formation in control and AD conditions. After 
compiling specie concentrations, the fold regulations from Dr. Castora’s work was used to 
determine the AD concentrations (Table 1). The values were then loaded into the model 
assuming that only one subunit could be absent from a functional complex. There is an 
overall decrease in available subunits including a decrease of approximately 2-fold in 
essential respirasome assembly subunit NDUFS1.  
After determining AD ETC concentrations, treatment sets were created by 
increasing one subunit concentration by 50% relative to AD concentrations. The 
concentration of individual complexes was reassessed with the treatment and shown in 
Table 2. The treatment sets were analyzed for how they affected CI stability via assembly 
with CIII and CIV. CIII is an important initial CI binding partner with CIV providing minor 
additional stability after CICIII formation (Lobo-Jarne et al., 2018). Subunit targets were  
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1 (uM) Control  AD 
UQCRFS1 13.62 7.41 
UQCRC1 9.57 3.75 
UQCRQ 5.14 2.49 
NDUFB9 7.42 2.52 
NDUFB4 10.06 9.22 
NDUFA11 1.85 0.84 
NDUFS1 6.29 2.44 
COX7A2L 3.54 2.04 
COX7A2 28.63 13.39 
 
selected based on their effect on CI or CIII concentrations compared to AD values. 
Simulations of SC assembly produced information about changes in respirasome 
concentration (Figure 11) and changes in the percent of CI: free CI, and sequestered by 
CICIII or respirasomes (Figure 12). The percentage of free CI in the AD sample is double 
that of the control, and the decreased respirasome formation (Figure 11 & 12) indicates 
that the AD tissue underwent a long period of oxidative stress. The CI subunit treatments 
2 (uM) Control AD UQCRC1 UQCRQ NDUFA11 NDUFS1 NDUFB9 
CI        
B9B4A11S1 1.85 0.84 0.84 0.84 1.26 0.84 0.84 
B9B4S1 4.44 1.60 1.60 1.60 1.18 2.83 2.93 
CIII        
FS1QC1 5.15 2.49 2.49 3.73 2.49 2.49 2.49 
FS1C1 
 
2.72 1.26 3.13 0.02 1.26 1.26 1.26 
Table 2: Initial concentrations of individual complexes based on control, AD and treatment 
subunit concentrations. Treatment sets were created by increasing one subunits 
concentration by 50%. Subunits that did not increase or decrease the concentration of 
complexes were not considered 
Table 1: Control and AD tissue ETC subunit concentrations given 
in uM. Complex abbreviations: UQCR- CIII, NDUF- CI, COX- CIV 
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predict that increasing respirasome concentration comes with an increase in free CI and 
potentially dangerous levels of ROS production. NDUFS1 and NDUFB9 treatments were 
able to increase the concentration of respirasome (Figure 12), but this increase in 
respirasome concentration was paralleled by an increase in free CI. UQCRC1 treatment 
was the only therapy predicted to increase respirasome formation and CI sequestration 
and ultimately a decreased percentage of free CI. Based on this model, we predict that 
Figure 11: Respirasome concentration (uM) in the control, AD, and treatment 
groups 
11 
2 
Figure 12: Percent of CI assembled into SCs (blue) respirasomes (green) or free 
(red) in control and treatment groups. 
12 
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targeting increased CIII binding to CI and not increasing available CI for respirasome 
binding is a viable treatment strategy to increase sequestration of CI and reduce ROS 
production related to CI activity. 
Oxidative Stress Model Results 
Mitochondrial biogenesis is a delicate process facilitating mitochondrial activity 
through increased antioxidant and mitochondrial subunit expression in response to 
changes in ATP and ROS production. When energy production cannot be salvaged and 
continual oxidative stress places the cell at risk of apoptosis, these response pathways 
activate autophagy and mitophagy. Our results predict that metabolic activity, ETC stability 
and electron saturation play important roles in ROS generation and mitochondrial 
oxidative stress. SIRT1 and AMPK are also an important for sending extra-mitochondrial 
stress signals which activate and transport transcription factors. 
An SA of the oxidative stress model was done to assess potential therapeutic 
targets. The analysis predicted that increased stable ETC, changes in metabolic enzymes 
3 ETC Metabolic  SIRT3 ATPsyn 
Concentration Sensitivity     
NADH -3.408 3.428 0.000 0 
O2 Radicals 0.003 0.563 0.000 0 
NADPH -0.013 -2.142 0.000 0 
Glutathione Dimer 0.003 0.996 0.000 0 
Flux Sensitivity     
Exported FOXO3 0.000 0.004 0.078 0 
Peroxide Formation 0.003 0.990 0.000 0 
e- capture 1.002 0.982 -0.016 0 
GSSG reduction 0.003 0.990 0.000 0 
FOXO3 export 0.000 0.006 0.130 0 
Table 3: Scaled SA analysis of the oxidative stress model to perturbations in therapy 
target species ETC, Metabolic Enzymes, SIRT3, and ATP synthase. Upper: sensitivity 
of key model species concentrations. Lower: Sensitivity of reaction fluxes to 
perturbations 
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and increased SIRT3 protein will decrease superoxide accumulation or activate the 
oxidative stress response. It also predicts that treatments dealing with ETC and metabolic 
enzyme concentrations will have opposing effects (Table 3). Increased metabolic activity 
meant that NADH levels increased, providing more substrate for energy production. 
However, as the literature also shows (Pryde & Hirst, 2011),  increased availability of 
NADH is linked to heightened superoxide levels as the ETC and CoQ pools become more 
reduced. The high levels of reduced ETC and CoQ lead to reverse electron transport and 
an increased potential for oxygen binding to CI. Both of these facilitate superoxide 
production. An increase in NADH can also dampen the ability of SIRT3 to increase 
antioxidant activity and activate FOXO3 export from the mitochondria. Decreased levels 
of NADPH and increasing glutathione dimers also indicate that changes in the metabolic 
activity affect the overall redox state of the mitochondria (Table 3). The minimal change in 
GSSG reduction and increased FOXO3 export indicate a higher level of stress and 
subsequent activation of a stress response.  Low changes in superoxide with increased 
stable ETC is in agreement with the literature (Ramírez-Camacho et al., 2019) that CI 
saturation with electrons (from NADH) leads to increased superoxide production. Higher 
levels of stable ETC complexes results in a lower percentage of these complexes existing 
in a reduced state. This limits the potential production of superoxide. Within the model, 
increasing the ETC did not change peroxide production (a common marker of superoxide 
production) compared to the control. As small amounts of peroxide production are 
important for normal mitochondrial signaling, if the SA results hold true at perturbations at 
higher than 1% this provides a promising avenue for targeting SC stability for AD 
treatment.  
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The SA indicated that metabolic enzymes had a negative effect on the model. 
Therefore, when considering treatments, we tested a 50% decrease in metabolic 
enzymes, as well as a 50% increase in SIRT3 and stable ETC. After an initial spike in 
activity related to beginning the model simulation, there is no change in superoxide 
production by the ETC while the metabolic enzyme treatment decreased superoxide 
production (Figure 13). As a certain level of peroxide is necessary for normal cell function, 
the benefits of metabolic enzyme treatment are likely highly sensitive to the exact enzymes 
and pathways being targeted.  
Figure 13: Percent difference in superoxide production compared to control. 
Therapy targets ETC and SIRT3 do not make a long term impact on the production 
of superoxide. Theoretical metabolic enzyme therapy reduces the superoxide 
production by approximately 50% 
13 
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The decreasing NADP+ concentration with metabolic treatment (Figure 14) 
demonstrates that the antioxidant cofactor is becoming more reduced with treatment and 
the mitochondria then has a heightened ability to eliminate ROS. As with superoxide 
production shown in Figure 13, the ETC stabilizing treatment does not affect NADPH 
levels. Another aspect of mitochondrial function is the availability of NAD and NADH. The 
NAD/NADH ratio governs metabolic activity and influences antioxidant cofactor 
availability. The control NAD/NADH ratio in this model is high compared to that found in 
living systems, but it is proportionally smaller than the cytoplasmic ratio as seen in the 
same living systems. Increasing SIRT3 made no difference in the NAD/NADH ratio despite 
use of NAD as a cofactor. For drug targets aimed to increase antioxidant activity, this is 
important as it predicts minimal unanticipated effects on normal mitochondrial activity. 
 
 
15 
Figure 14: Percent change in NADP+ concentration with ETC, metabolic 
enzyme and SIRT3 treatment compared to control.  
14 
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4 AMPK LKB1 SIRT1 
Concentration Sensitivities   
PGC1α 0.000 0.000 0.001 
FOXO3 0.029 0.001 0.578 
NAD/NADH 0.587 0.346 0.003 
Flux Sensitivities    
NAM to NMN 0.026 0.022 0.587 
AMPK activation 0.000 0.481 0.587 
NADH oxidation 0.016 0.009 0.000 
    
 This predicts that increased SIRT activity may be a way of strengthening mitochondrial 
stress response without interfering with normal respiratory activity.  Consistent with Figure 
15 and Table 4, decreasing metabolic enzymes had a beneficial impact on the NAD/NADH 
ratio. Increasing stable ETC leads to a notably higher ratio. This higher ratio favors 
activation of antioxidant pathways which can decompose any stress-related increases in 
superoxide not handled by the decreased demand and oxidation of the individual 
complexes.  
 The SAs of cytosolic therapy targets highlight important relationships between the 
signaling pathways, feedback loops and transcription factor activation. Both AMPK and 
LKB1 had a minor impact on PGC1α and FOXO3 activation (Table 4), but were able to 
increase the flux of NMN synthesis, an indicator of SIRT1 activity and the AMPK positive 
feedback loop. The sensitivity of active FOXO3 to SIRT1 concentrations indicates that 
SIRt1 is important for FOXO3 activation. However, there is potential for AMPK treatment 
to increase the positive feedback loop with SIRT1 to increase FOXO3 activation. The 
Table 4: Cytosolic Target SA Upper: Sensitivities of active transcription factor 
concentration and NAD/NADH ratio to targets AMPK, LKB1 and SIRT1. Lower: 
Sensitivities of reaction fluxes to perturbations in enzyme concentrations. 
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correlation between AMPK activity and the NAD/NADH ratio (Table 4) results in the 
beneficial increase in SIRT1 activity shown by the increase in nicotinamide (NAM).  
The cytosolic reactions shown in this model are only in response to oxidative 
stress. They are analyzed for changes in transcription factor activation. PGC1α and 
FOXO3 both require SIRT1 deacetylation and AMPK phosphorylation to enter the nucleus. 
The activity of these proteins is increased with increasing oxidative stress in vitro (Duan 
et al., 2016), but this model shows a preferential activation of FOXO3 (Figure 16). There 
was no change in ATP/AMP ratio.  
Figure 15: Changes in mitochondrial NAD/NADH ratios with target treatments. 
Metabolic enzyme treatment (blue) made the largest impact on the NAD/NADH 
ratio. The stabilized ETC treatment (green) caused the ratio to triple while SIRT3 
treatment (purple) did not change the NAD/NADH ratio 
15 
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The model predicted that FOXO3 
is preferentially activated by oxidative 
stress. The lack of PGC1α activation 
indicates that it is more sensitive to ATP 
availability and production which 
deactivates AMPK. SIRT1 is predicted to 
be the more effective therapeutic target 
due to the changes in the FOXO3a 
activation and its widespread impact on 
autophagy activation (Figure 16). AMPK 
is a second potential target. It plays an 
important role in both FOXO3 and PGC1α 
activation, but the low PGC1α activation 
in this model hints that changes in ATP 
availability may be more important for 
PGC1α activation than FOXO3. 
Depending on the goal of therapy 
(eliminate dysfunctional mitochondria or 
restore respiratory activity) different 
targets should be considered.  
Discussion 
 The MC hypothesis predicts that 
deficits in respiratory chain efficiency lead 
to ROS accumulation as we age and 
predisposes individuals to the onset of 
Figure 16: Transcription factor activation with 
therapy targets SIRT1 (A), LKB1 (B), and 
AMPK (C). The model predicts that FOXO3 will 
be preferentially activated by changes in ROS 
production. AMPK and SIRT1 are the most 
effective treatment options.  
16 
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neurodegenerative diseases (Mosconi, 2013). The work of Dr. Castora’s lab complements 
this hypothesis, showing that there are changes in respiratory chain gene expression 
levels in individuals with AD. Using this information on gene expression, we created two 
models investigating the impacts such differences can have in respiratory function and 
subsequent stress-related signaling. ROS production increases the activity of SIRT3, 
SOD2, Cat, and Gpx to prevent oxidative damage to surrounding tissues and 
mitochondrial DNA (Ighodaro & Akinloye, 2017). If this constitutive antioxidant system 
cannot reduce ROS, SIRT3 activates a signaling cascade inducing FOXO3 and PGC1α 
mediated transcription of antioxidant and autophagic genes (Brenmoehl & Hoeflich, 2013). 
Specific transcription factor activation is important for disease onset and well as mitigation. 
By activating the correct transcription factor, we can direct activation of beneficial 
pathways and prevent the activation of detrimental pathways. This model predicts that 
ROS production does not directly affect ATP production, but preferentially activates the 
FOXO3 transcription factor. Therefore, a decrease in ATP resulting from lower respiratory 
activity better activates AMPK, initiating PGC1α activation and mitochondrial biogenesis. 
As FOXO3 transcriptional targets activates autophagy as well as antioxidant proteins, this 
avenue of treatment should be considered with caution. Moderate increases in activity will 
likely activate the clearance of ROS and dysfunctional mitochondria, but if changes are 
too large they can result in a hyperactive autophagy pathway which is more cytotoxic than 
neuroprotective.  SIRT1 is a viable target as it is predicted to be important for both FOXO3 
and PGC1α activation. AMPK would be effective in upregulating PGClα and increasing 
mitochondrial biogenesis inducing the feedback loop to SIRT1 activation. Picking AMPK-
related targets may also provide more balance between FOXO3 and PGC1α activation to 
prevent conservation of irreversibly dysfunctional mitochondria that put the entire neuron 
at risk.  
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 Respiratory and metabolic targets present a safer therapeutic avenue. By picking 
targets that increase stable SC formation, we can decrease ROS production at its root 
with fewer risks of aberrant pathway or signaling changes. CICIII formation is the most 
important step in reducing CI related ROS production. By covering one of two oxygen 
binding sites as well as increasing CI binding partners, CIII subunit UQCRC1 is predicted 
to be the most effective subunit target. The model shadowed this prediction as seen in the 
increase in CI sequestered within SC’s.  
 These model predictions about transcription factor activation and SC assembly 
may be of importance when understanding the mitochondrial differences between elder 
and long-lived individuals. People who live to be older than 75 years have defective 
mitochondria with high peroxide concentrations and low ATP levels (Sgarbi et al., 2014). 
The results of this model would predict that this unique trait may be due to sequential 
changes in gene transcription allowing for mitochondrial fusion (changes in bioenergetics) 
before autophagy activation. This sequence could prevent autophagic degradation 
because the hyperfusion of mitochondria make them resistant to degradation. It is unclear 
how this adaptation relates to AD, but the correlation with lifespan is favorable. Further 
work studying the effects of subunit and antioxidant therapies on mitochondrial stress 
response in vitro to assess the utility of these treatments is required to confirm these 
predictions.   
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Appendix 
S1: Complete SC model 
  
S1:  Model of potential SC assemblies based on Subunit expression. CI is shown in light blue, CIII 
in red and CIV in purple. SC CICIII is shown in purple, CIVCIII in orange and Respirasome in white. 
The letter and number pairs represent the potential groupings of subunits (CI(blue): B9=NDUFB9, 
B4=NDUFB4, A11=NDUFA11 and S1=NDUFS1; CIII(red): FS1=UQCRFS1, Q=UQCRQ, and 
C1=UQCRC1; CIV(orange): 7AL=COX7AL, and 7A2=COX7A2). CICIII is differentiated by the 
number of stable inter-complex bonds being formed with 3 being the most in 1 the least. The prefix 
“s” represents the presence of CI subunit NDUFS1,an essential subunit for respirasome formation. 
This models represents all potential combinations.  
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S2: SC assembly model ODE system 
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S3: SC assembly Kinetic Parameters      
     
  re647   µmol/(l*s) 
   k1  0.5 l/(µmol*s) 
   k2  0.05 1/s 
  re648   µmol/(l*s) 
   kf_re648  0.3 1/(µmol*s) 
   kr_re648  0.05 1/s 
  re649   µmol/(l*s) 
   kf_re649  0.7 1/(µmol*s) 
   kr_re649  0.05 1/s 
  re650   µmol/(l*s) 
   kf_re650  0.7 1/(µmol*s) 
   kr_re650  0.05 1/s 
  re652   µmol/(l*s) 
   kf_re652  0.8 1/(µmol*s) 
   kr_re652  0.05 1/s 
  re654   µmol/(l*s) 
   kf_re654  0.8 1/(µmol*s) 
   kr_re654  0.05 1/s 
  re657   µmol/(l*s) 
   kf_re657  0.9 1/(µmol*s) 
   kr_re657  0.01 1/s 
  re661   nan µmol/(l*s) 
   kf_re661  0.8 1/(µmol*s) 
   kr_re661  0.05 1/s 
  re666   nan µmol/(l*s) 
   kf_re666  0.3 1/(µmol*s) 
   kr_re666  0.01 1/s 
  re690   nan µmol/(l*s) 
   kf_re690  0.3 1/(µmol*s) 
   kr_re690  0.05 1/s 
  re693   nan µmol/(l*s) 
   kf_re693  0.3 1/(µmol*s) 
   kr_re693  0.05 1/s 
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S3: Detailed Oxidative Stress Model 
  
S3: Oxidative stress model showing each explicit reaction used to create the 
differential equation system.  
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S4: Oxidative Stress Model Equations 
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S6: Oxidative Stress Model Final Parameter Set and Concentrations 
Initial State      
 Initial Compartment Sizes     
  default   1 l 
  matrix   6.83e-19 l 
  inner membrane space   2.28e-19 l 
  cell   1e-13 l 
 Initial Species Values     
  ETC   4.408 µmol/(l) 
  ATPsyn   26.9466 µmol/(l) 
  SOD2   53.759 µmol/(l) 
  NADH{matrix}   12 µmol/(l) 
  aSOD2   17.9197 µmol/(l) 
  Cat   15.1617 µmol/(l) 
  AMP{matrix}   0.0014 µmol/(l) 
  ATP{matrix}   1390 µmol/(l) 
  GSSG   0.041 µmol/(l) 
  GSH   1.2 µmol/(l) 
  NADP+   19.6 µmol/(l) 
  NADPH   51 µmol/(l) 
  GPx   17.4155 µmol/(l) 
  GR   0.5972 µmol/(l) 
  LKB1   0.1789 µmol/(l) 
  aLKB1   0.0596 µmol/(l) 
  AMPK   0.0533 µmol/(l) 
  PRPP{matrix}  6.67 µmol/(l) 
  PPi{matrix}  0 µmol/(l) 
  NMN{matrix}  0.0589 µmol/(l) 
  NAD{matrix}  50 µmol/(l) 
  SIRT3   0.0075 µmol/(l) 
  NAM{matrix}  0.4809 µmol/(l) 
  aSIRT3   0.0013 µmol/(l) 
  aAMPK   0.0178 µmol/(l) 
  SIRT1   0.0036 µmol/(l) 
  aFOXO3  0.00099 µmol/(l) 
  PPi{cell}  0 µmol/(l) 
  PRPP{cell}  4.9 µmol/(l) 
  NMN{cell}  0.0589 µmol/(l) 
  NAMPT   0.4809 µmol/(l) 
  NMNAT  0.0049 µmol/(l) 
  NMNAT3  0.0664 µmol/(l) 
  inhib{matrix}  0.0012 µmol/(l) 
  NAM{cell}  0.4809 µmol/(l) 
  NAD{cell}  85 µmol/(l) 
  ATP{cell}  1390 µmol/(l) 
  AMP{cell}  0.0014 µmol/(l) 
  O2'   0 µmol/(l) 
  H2O2   10.5 µmol/(l) 
  H+{matrix}  0.0048 µmol/(l) 
  H+{"inner membrane space"} 0.1 µmol/(l) 
  H2O   0 µmol/(l) 
  O2   32 µmol/(l) 
  NADH{cell}   1.17 µmol/(l) 
  inhib{cell}   0.0012 µmol/(l) 
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  e    0 µmol/(l) 
  IDH2    8.7951 µmol/(l) 
  aPGC1a   1.1e-05 µmol/(l) 
  pac_PGC1a   7.7e-05 µmol/(l) 
  ac_PGC1a   1.65e-05 µmol/(l) 
  p_ac_FOXO3   0.003 µmol/(l) 
  ac_FOXO3{cell}  0.0118 µmol/(l) 
  FOXO3    0.0039 µmol/(l) 
  aIDH2    2.9317 µmol/(l) 
  metabolic   1 µmol/(l) 
  UCP5    1 µmol/(l) 
 Initial Global Quantities     
  Proton Grad   20.8333 dimensionless 
  ATP/AMP {matrix}  992857 dimensionless 
  NAD/NADH {cyto}  72.6496 dimensionless 
  NAD/NADH {matrix}  4.16667 dimensionless 
 Kinetic Parameters     
  SIRT3 deact    
   k1   0.0607443 1/min 
  SIRT3 disinhib    
   k1   0.031598 1/min 
  NAD rdxn {matrix}    
   kcat_re40_s105 9.184 1/min 
   kmc_re40_s102_s105 1.5072e-06 µmol/l 
  AMP transport    
   kf_re46  1e-05 1/min 
  ATP consump {mtx}    
   k1  0.125164 1/min 
  SOD2 deact    
   k1  0.00271808 1/min 
  AMPK deact    
   kf_re21  0.0183318 l/(µmol*min) 
  FOXO3 dephos    
   k1  1.24677e-05 1/min 
  NAM->NMN{mtx}    
   k1  111.534 l/(µmol*min) 
  LKB1 deact    
   k1  0.0338412 1/min 
  FOXO3 to matrix    
   kf_re35  0.0278129 1/min 
  SIRT3 inhib    
   k1  1e-05 l/(µmol*min) 
  SIRT1 disinhib    
   k1  1.09474 1/min 
  NADH oxdtn {cyto}    
   k1  0.13173 1/min 
  ATP export    
   kf_re47  17.5096 1/min 
  ATP hydrolysis    
   k1  0.23558 1/min 
  SIRT1 inhib    
   k1  0.0103606 l/(µmol*min) 
  NAD rdxn {cyto}   
   k1    0.00513173 1/min 
  PGC1a acyl    
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   k1    0.00109024 1/min 
  PGC1a    
   k1    0.0386717 1/min 
  FOXO3a deact    
   k1    0.0195509 1/min 
  H2O2 decomp (Cat)    
   kcat_re10_s3   0.001248 1/min 
   kmc_re10_s18_s3  7.36 µmol/l 
  SIRT3 act    
   kcat_re1_s14   0.0257019 1/min 
   kmc_re1_s5_s14  0.0153836 µmol/l 
  e capture    
   kcat_re9_s21   1.264e-05 1/min 
   kmc_re9_s17_s21  0.0353064 µmol/l 
   kmc_re9_s11_s21  0.0143592 µmol/l 
   kmc_re9_s6_s21  0.0242807 µmol/l 
  O2 rad formation    
   k1    1e-05 l/(µmol*min) 
  NADH ox (ETC)    
   kcat_re7_s21   2.94443 1/min 
   kmc_re7_s16_s21  0.458844 µmol/l 
  Peroxide formation (SOD2)    
   kcat_re4_s24   27.456 1/min 
   kmc_re4_s14_s24  0.007 µmol/l 
   kmc_re4_s6_s24  0.004992 µmol/l 
   kic_re4_s14_s24  0.01 µmol/l 
  NMN->NAD{matrix}    
   kcat_re27_s51   112.176 1/min 
   kmc_re27_s47_s51  87.1298 µmol/l 
  H2O2 decomp (Gpx)    
   kcat_re11_s63   30.4704 1/min 
   kmc_re11_s18_s63  5 µmol/l 
   kmc_re11_s60_s63  2.88 µmol/l 
   kic_re11_s18_s63  0.00408 µmol/l 
  GSSG rdxn    
   kcat_re18_s64   304.261 1/min 
   kmc_re18_s59_s64  37.516 µmol/l 
   kmc_re18_s62_s64  7.6109 µmol/l 
   kic_re18_s59_s64  0.0117007 µmol/l 
  AMPK activation    
   kcat_re20_s70   2.16999 1/min 
   kmc_re20_s29_s70  14.7446 µmol/l 
   kmc_re20_s116_s70  18.14 µmol/l 
   kic_re20_s29_s70  7.40837 µmol/l 
  ATP syn    
   kcat_re14_s83   1e-05 1/min 
   kmc_re14_s20_s83  0.226778 µmol/l 
   kmc_re14_s90_s83  0.0743971 µmol/l 
   kic_re14_s20_s83  0.110651 µmol/l 
  SOD2 act    
   kcat_re13_s85   1.44757 1/min 
   kmc_re13_s22_s85  1e-05 µmol/l 
   kmc_re13_s4_s85  1e-05 µmol/l 
   kic_re13_s22_s85  0.0787856 µmol/l 
  FOXO3a exp    
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   kcat_re24_s85   3.24781 1/min 
   kmc_re24_s81_s85  1e-05 µmol/l 
   kmc_re24_s4_s85  1e-05 µmol/l 
   kic_re24_s81_s85  132.145 µmol/l 
  NADH ox    
   kcat_re54_s86   1213.99 1/min 
   kmc_re54_s123_s86  7.18526 µmol/l 
  PGC1a phos    
   kcat_re69_s86   5.43493 1/min 
   kmc_re69_s133_s86  0.00896693 µmol/l 
  FOXO3a phos    
   kcat_re36_s86   1.07218 1/min 
   kmc_re36_s34_s86  0.0239716 µmol/l 
  LKB1 act    
   kcat_re37_s88   0.269103 1/min 
   kmc_re37_s69_s88  31.4614 µmol/l 
   kmc_re37_s114_s88  205.788 µmol/l 
   kic_re37_s69_s88  5.27956 µmol/l 
  FOXO3 act    
   kcat_re13_s85   159.577 1/min 
   kic_re13_s22_s85  260.251 µmol/l 
   kmc_re13_s22_s85  117.909 µmol/l 
   kmc_re13_s4_s85  1.95425 µmol/l 
  PGC1 deacyl    
   kcat_re13_s85   0.0220595 1/min 
   kic_re13_s22_s85  53.1197 µmol/l 
   kmc_re13_s22_s85  183.867 µmol/l 
   kmc_re13_s4_s85  2.67021 µmol/l 
  NAM->NMN{cell}    
   kcat_re38_s104  21.1889 1/min 
   kmc_re38_s113_s104  41.2056 µmol/l 
   kmc_re38_s101_s104  0.860579 µmol/l 
   kic_re38_s113_s104  0.00753388 µmol/l 
  NMN->NAD{cell}    
   kcat_re40_s105  0.655759 1/min 
   kmc_re40_s102_s105  47.1165 µmol/l 
  NADP rdxn    
   kcat_re73_s127  1e-05 1/min 
   kmc_re73_s61_s127  12.0712 µmol/l 
   kmc_re73_s6_s127  99.8827 µmol/l 
   kic_re73_s61_s127  0.01616 µmol/l 
  IDH2 deact    
   k1    0.0444651 1/min 
  IDH2 act    
   kcat_re86_s5   50.985 1/min 
   kmc_re86_s127_s5  1e-05 µmol/l 
   kmc_re86_s4_s5  4.62915 µmol/l 
   kic_re86_s127_s5  1e-05 µmol/l 
  H+ leak    
   k1    0.00026904 1/min 
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S7: Initial Oxidative Stress Model Parameter Values 
 
Initial State     
 Kinetic Parameters     
  SIRT3 deact   nan µmol/(l*min) 
   k1  1.8 1/min 
  SIRT3 disinhib   nan µmol/(l*min) 
   k1  0.0197 1/min 
  NAD rdxn {matrix}   nan µmol/(l*min) 
   kcat_re40_s105 1.04781 1/min 
   kmc_re40_s102_s105  0.021257 µmol/l 
  AMP transport   nan µmol/(min) 
   kf_re46  0.24 1/min 
  ATP consump {mtx}   nan µmol/(l*min) 
   k1  0.204 1/min 
  SOD2 deact   nan µmol/(l*min) 
   k1  0.03 1/min 
  AMPK deact   nan µmol/(l*min) 
   kf_re21  0.039 l/(µmol*min) 
  FOXO3 dephos   nan µmol/(l*min) 
   k1  0.0001 1/min 
  NAM->NMN{mtx}   nan µmol/(l*min) 
   k1  32 l/(µmol*min) 
  LKB1 deact   nan µmol/(l*min) 
   k1  0.03 1/min 
  FOXO3 to matrix   nan µmol/(min) 
   kf_re35  0.24 1/min 
  SIRT3 inhib   nan µmol/(l*min) 
   k1  0.197 l/(µmol*min) 
  SIRT1 disinhib   nan µmol/(l*min) 
   k1  1.79 1/min 
  NADH oxdtn {cyto}   nan µmol/(l*min) 
   k1  0.05 1/min 
  ATP export   nan µmol/(min) 
   kf_re47  9.6 1/min 
  ATP hydrolysis   nan µmol/(l*min) 
   k1  0.204 1/min 
  SIRT1 inhib   nan µmol/(l*min) 
   k1  0.01 l/(µmol*min) 
  NAD rdxn {cyto}  nan µmol/(l*min) 
   k1  0.01 1/min 
  PGC1a acyl   nan µmol/(l*min) 
   k1  0.03 1/min 
  PGC1a   nan µmol/(l*min) 
   k1  0.03 1/min 
  FOXO3a deact   nan µmol/(l*min) 
   k1  0.03 1/min 
  H2O2 decomp (Cat)   nan µmol/(l*min) 
   kcat_re10_s3  0.0012 1/min 
   kmc_re10_s18_s3  20 µmol/l 
  SIRT3 act   nan µmol/(l*min) 
   kcat_re1_s14  0.03 1/min 
   kmc_re1_s5_s14  0.2 µmol/l 
  e capture   nan µmol/(l*min) 
   kcat_re9_s21  10 1/min 
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   kmc_re9_s17_s21  0.01 µmol/l 
   kmc_re9_s11_s21  0.01 µmol/l 
   kmc_re9_s6_s21  0.01 µmol/l 
  O2 rad formation   nan µmol/(l*min) 
   k1  0.57 l/(µmol*min) 
  NADH ox (ETC)  nan µmol/(min) 
   kcat_re7_s21  1 1/min 
   kmc_re7_s16_s21  0.01 µmol/l 
  Peroxide formation (SOD2)   nan µmol/(l*min) 
   kcat_re4_s24  24 1/min 
   kmc_re4_s14_s24  0.005 µmol/l 
   kmc_re4_s6_s24  0.005 µmol/l 
   kic_re4_s14_s24  0.01 µmol/l 
  NMN->NAD{matrix}   nan µmol/(l*min) 
   kcat_re27_s51  150 1/min 
   kmc_re27_s47_s51  66.2 µmol/l 
  H2O2 decomp (Gpx)   nan µmol/(l*min) 
   kcat_re11_s63  31.74 1/min 
   kmc_re11_s18_s63  5 µmol/l 
   kmc_re11_s60_s63  2 µmol/l 
   kic_re11_s18_s63  0.01 µmol/l 
  GSSG rdxn   nan µmol/(l*min) 
   kcat_re18_s64  144 1/min 
   kmc_re18_s59_s64  56.7 µmol/l 
   kmc_re18_s62_s64  7.9 µmol/l 
   kic_re18_s59_s64  0.01 µmol/l 
  AMPK activation   nan µmol/(l*min) 
   kcat_re20_s70  10 1/min 
   kmc_re20_s29_s70  67.2 µmol/l 
   kmc_re20_s116_s70  48 µmol/l 
   kic_re20_s29_s70  67.2 µmol/l 
  ATP syn   nan µmol/(min) 
   kcat_re14_s83  0.5 1/min 
   kmc_re14_s20_s83  0.1 µmol/l 
   kmc_re14_s90_s83  0.1 µmol/l 
   kic_re14_s20_s83  0.01 µmol/l 
  SOD2 act   nan µmol/(l*min) 
   kcat_re13_s85  0.197 1/min 
   kmc_re13_s22_s85  25.5 µmol/l 
   kmc_re13_s4_s85  140 µmol/l 
   kic_re13_s22_s85  29.4 µmol/l 
  FOXO3a exp   nan µmol/(min) 
   kcat_re24_s85  0.197 1/min 
   kmc_re24_s81_s85  25.5 µmol/l 
   kmc_re24_s4_s85  673.3 µmol/l 
   kic_re24_s81_s85  29.4 µmol/l 
  NADH ox   nan µmol/(l*min) 
   kcat_re54_s86  270 1/min 
   kmc_re54_s123_s86  8 µmol/l 
  PGC1a phos   nan µmol/(l*min) 
   kcat_re69_s86  3.42 1/min 
   kmc_re69_s133_s86  0.0093 µmol/l 
  FOXO3a phos   nan µmol/(l*min) 
   kcat_re36_s86  0.72 1/min 
   kmc_re36_s34_s86  0.26 µmol/l 
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  LKB1 act   nan µmol/(l*min) 
   kcat_re37_s88  14.4 1/min 
   kmc_re37_s69_s88  25.5 µmol/l 
   kmc_re37_s114_s88  82.6 µmol/l 
   kic_re37_s69_s88  60.5 µmol/l 
  FOXO3 act   nan µmol/(l*min) 
   kcat_re13_s85  14.4 1/min 
   kic_re13_s22_s85  60.5 µmol/l 
   kmc_re13_s22_s85  82.6 µmol/l 
   kmc_re13_s4_s85  25.5 µmol/l 
  PGC1 deacyl   nan µmol/(l*min) 
   kcat_re13_s85  14.4 1/min 
   kic_re13_s22_s85  60.5 µmol/l 
   kmc_re13_s22_s85  82.6 µmol/l 
   kmc_re13_s4_s85  25.5 µmol/l 
  NAM->NMN{cell}   nan µmol/(l*min) 
   kcat_re38_s104 32 1/min 
   kmc_re38_s113_s104  22.9 µmol/l 
   kmc_re38_s101_s104  2.67 µmol/l 
   kic_re38_s113_s104  0.05 µmol/l 
  NMN->NAD{cell}   nan µmol/(l*min) 
   kcat_re40_s105 150 1/min 
   kmc_re40_s102_s105  66.2 µmol/l 
  NADP rdxn   nan µmol/(l*min) 
   kcat_re73_s127 14400 1/min 
   kmc_re73_s61_s127  7.9 µmol/l 
   kmc_re73_s6_s127  56.7 µmol/l 
   kic_re73_s61_s127  0.01 µmol/l 
  IDH2 deact   nan µmol/(l*min) 
   k1  0.03 1/min 
  IDH2 act   nan µmol/(l*min) 
   kcat_re86_s5  14.4 1/min 
   kmc_re86_s127_s5  82.6 µmol/l 
   kmc_re86_s4_s5  25.5 µmol/l 
   kic_re86_s127_s5  60.5 µmol/l 
  H+ leak   nan µmol/(l*min) 
   k1  1e-05 1/min 
 
